Our study suggests that EGFR and DOCK4-mediated RAC1 activation in response to secreted brain endothelial factors oppose this contractile phenotype, allowing cancer cells to cross the endothelium and propel themselves into the brain parenchyma (Fig. 5l). The gene discussed is RAC1; the disease is cancer.